About
RemedyBio uses a proprietary single cell analysis technology at the core of its nanoreactor platform, for the discovery of new targets and therapies in immune oncology, through the analysis and viable recovery of cells from patient tumour samples. These include antibodies and cell therapies against solid tumours.
Ashley Nagle
VP BDBD anagle@remedybiologics.com
Website
View WebsiteAddress
The Digital Depot
The Digital Hub
D08 TCV4
Dublin
Ireland
Areas of Expertise
- Analytics
- Cell Therapy (Autologous)
- Clinical
- Data Analysis
- Discovery
- Microscopy/Imaging
- Regulatory